|Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging.|
|Jump to Full Text|
|PMID: 23448364 Owner: NLM Status: MEDLINE|
|Oxidative stress is a determining factor of cellular senescence and aging and a potent inducer of the tumour-suppressor p53. Resistance to oxidative stress correlates with delayed aging in mammals, in the absence of accelerated tumorigenesis, suggesting inactivation of selected p53-downstream pathways. We investigated p53 regulation in mice carrying deletion of p66, a mutation that retards aging and confers cellular resistance and systemic resistance to oxidative stress. We identified a transcriptional network of ~200 genes that are repressed by p53 and encode for determinants of progression through mitosis or suppression of senescence. They are selectively down-regulated in cultured fibroblasts after oxidative stress, and, in vivo, in proliferating tissues and during physiological aging. Selectivity is imposed by p66 expression and activation of p44/p53 (also named Delta40p53), a p53 isoform that accelerates aging and prevents mitosis after protein damage. p66 deletion retards aging and increases longevity of p44/p53 transgenic mice. Thus, oxidative stress activates a specific p53 transcriptional response, mediated by p44/p53 and p66, which regulates cellular senescence and aging.|
|Valentina Gambino; Giulia De Michele; Oriella Venezia; Pierluigi Migliaccio; Valentina Dall'Olio; Loris Bernard; Simone Paolo Minardi; Maria Agnese Della Fazia; Daniela Bartoli; Giuseppe Servillo; Myriam Alcalay; Lucilla Luzi; Marco Giorgio; Heidi Scrable; Pier Giuseppe Pelicci; Enrica Migliaccio|
Related Documents :
|15301324 - Evidence-based therapies for myocardial infarction: secular trends and determinants of ...
20439064 - Potentially inappropriate medication use in elderly japanese patients.
17668524 - Pediatric acne: clinical presentations, evaluation, and management.
23050124 - Hsp70 and hsp90 differentially regulate translocation of extracellular antigen to the c...
1602844 - (-)deprenyl and (-)parafluorodeprenyl-treatment prevents age-related pigment changes in...
2641704 - Intestinal leiomyosarcoma following treatment of osteosarcoma in a teenage girl.
|Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2013-03-27|
|Title: Aging cell Volume: 12 ISSN: 1474-9726 ISO Abbreviation: Aging Cell Publication Date: 2013 Jun|
|Created Date: 2013-05-14 Completed Date: 2013-08-14 Revised Date: 2013-11-07|
Medline Journal Info:
|Nlm Unique ID: 101130839 Medline TA: Aging Cell Country: England|
|Languages: eng Pagination: 435-45 Citation Subset: IM|
|© 2013 John Wiley & Sons Ltd and the Anatomical Society.|
|European Institute of Oncology, Via Ripamonti 435, Milan, 20141, Italy.|
|APA/MLA Format Download EndNote Download BibTex|
Cell Aging / genetics, physiology*
Cell Cycle / genetics, physiology
Hepatocytes / metabolism
Oxidative Stress / physiology*
Peptide Fragments / metabolism*
Protein Isoforms / genetics, metabolism
Shc Signaling Adaptor Proteins / genetics, metabolism*
Thymus Gland / metabolism
Tumor Suppressor Protein p53 / genetics, metabolism*
|1P01AG025532-01A1/AG/NIA NIH HHS; P01 AG025532/AG/NIA NIH HHS|
|0/Peptide Fragments; 0/Protein Isoforms; 0/Shc Signaling Adaptor Proteins; 0/Shc1 protein, mouse; 0/Tumor Suppressor Protein p53; 0/p44 protein, mouse|
Journal ID (nlm-ta): Aging Cell
Journal ID (iso-abbrev): Aging Cell
Journal ID (publisher-id): acel
Publisher: Blackwell Publishing Ltd
© 2013 John Wiley & Sons Ltd and the Anatomical Society
Accepted Day: 18 Month: 2 Year: 2013
Print publication date: Month: 6 Year: 2013
Electronic publication date: Day: 27 Month: 3 Year: 2013
Volume: 12 Issue: 3
First Page: 435 Last Page: 445
PubMed Id: 23448364
|Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging|
|Giulia De Michele1|
|Simone Paolo Minardi3|
|Maria Agnese Della Fazia4|
|Pier Giuseppe Pelicci15|
1European Institute of OncologyVia Ripamonti 435, Milan, 20141, Italy
2Dipartimento di Scienze Biomediche - Sez. di Anatomia Umana, University of SienaSiena, 53100, Italy
3Firc Institute for Molecular OncologyVia Adamello 16, Milan, 20139, Italy
4Dipartimento di Medicina Clinica e Sperimentale, Facoltà di Medicina e Chirurgia, University of PerugiaPerugia, 06100, Italy
5Dipartimento di Medicina, Chirurgia e Odontoiatria, University of MilanMilan, 20142, Italy
6Mayo Clinic, University of Massachusetts Medical SchoolWorcester, MN, 55905, USA
|Correspondence: Pier Giuseppe Pelicci and Enrica Migliaccio, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Tel.: 39-02-94375028; fax: 39-02-94375990; e-mail: email@example.com; firstname.lastname@example.org
It is postulated that ROS, which form endogenously from metabolism, induce intracellular oxidative stress that increases during lifespan and is mechanistically implicated in various aging phenotypes. Molecular targets of ROS include DNA and intracellular macromolecules such as proteins and membrane lipids (Giorgio et al., 2007; Muller et al., 2007). Cells activate different mechanisms in response to oxidative stress, including repair pathways, inhibition of cellular proliferation (transient cell-cycle arrest or senescence), or apoptosis. Notably, senescent cells accumulate in various tissues and organs with aging and have been causally implicated in generating age-related phenotypes (Baker et al., 2011).
In mammals, increased resistance to oxidative stress is consistently associated with delayed aging, resistance to aging-related diseases and enhanced longevity. In fact, cellular and systemic resistance to pro-oxidants (measured as survival upon hydrogen peroxide – H2O2 – or paraquat treatments, respectively) has been documented in all the long-lived mutant mice tested, including Klotho and dwarf mice; mice overexpressing thioredoxin or the urokinese-type plasminogen activator; mice carrying homozygote deletion of the growth hormone receptor (GHR−/−), p66shc (p66−/−) or the insulin receptor in the fat tissue (FIRKO); mice with heterozygous mutations of the Igf1 receptor (IGF1R+/−) or the Clk-1 gene (Clk+/−). Enhanced resistance to oxidative stress has been also reported in mice subjected to calorie restriction (CR), a most effective method to extend mammalian lifespan via environmental factors (Salmon et al., 2005, 2010; Brown-Borg, 2006; Ikeno et al., 2009).
The underlying molecular mechanisms are unclear. An increase in anti-oxidative defence mechanisms, including both enzymatic and nonenzymatic systems, was shown in a few long-lived strains (e.g. dwarf mice) but is controversial (CR mice) or not seen (GHR−/−; FIRKO or p66−/− mice) in others (Hauck et al., 2002; Bluher et al., 2003, 2004; Bokov et al., 2004). Notably, over-expression of anti-oxidant enzymes in mice leads to increased oxidative-stress resistance, but except for mitochondrial catalase and thioredoxin, does not prolong lifespan (Huang et al., 2000; Giorgio et al., 2005; Jang et al., 2009; Perez et al., 2009, 2011; Ristow & Schmeisser, 2011). Conversely, mice with genetically reduced levels of single components of the anti-oxidant system do not show reduced lifespan (Schriner et al., 2005; Zhang et al., 2009). Thus, other mechanisms might be responsible for increased oxidative-stress resistance and enhanced longevity of long-lived mice.
Oxidative stress is a potent inducer of the tumour-suppressor p53, which mediates all the antiproliferative cellular responses to oxidative signals, including transient cell-cycle arrest, cellular senescence or apoptosis (Johnson et al., 1996). Interestingly, primary cells from long-lived and p53−/− mice are similarly resistant to H2O2 treatment (Migliaccio et al., 1999; Trinei et al., 2002), suggesting that activation of p53 signalling by oxidative stress is defective in cells from long-lived mouse models. Attenuation of p53 function, however, is invariably associated with increased tumour formation in mammals, which is, instead, absent in the long-lived mice (Hursting et al., 1994; Migliaccio et al., 1999; Ikeno et al., 2003, 2009; Giorgio et al., 2005; Alderman et al., 2009). On the contrary, several longevity strains showed reduced cancer occurrence (dwarf, GHR−/− and CR mice).
We report here our investigations on the role of p53 in the increased resistance to oxidative stress of longevous mice, using p66−/− mice as model. p66 is a redox protein that uses reducing equivalents of the mitochondrial electron-transfer chain to generate reactive oxygen species (ROS) (Migliaccio et al., 2006). Deletion of p66 in mice induces oxidative-stress resistance, both at systemic and at cellular levels, decreased penetrance of aging-associated diseases (obesity, atherosclerosis, ischaemic injury and diabetes) and delayed aging (Migliaccio et al., 2006).
To investigate the role of p66 in p53 transcriptional response to oxidative stress, we analysed mRNA profiles of WT, p53−/− and p66−/− mouse embryonic fibroblasts (MEFs; 4 independent preparations from sv129 mice) after high-dose of H2O2 (Dataset S1). WT MEFs entered both apoptosis and cell-cycle arrest, as previously reported (Lim et al., 2008; Gutierrez-Uzquiza et al., 2010). In particular, ∼20% of cells underwent apoptosis (Fig. 1A), while near all the others exited the cell cycle (Fig. 1B, left), with ∼25% acquiring signs of senescence (flat and enlarged morphology, positivity to SA-β-Gal–staining; Figs. 1B, right and S1). p66−/− and p53−/− MEFs showed an attenuated apoptotic response and were almost completely unable to exit the cell cycle (Figs 1A,B and S1).
Analysis of mRNA-expression modifications induced by oxidative stress in WT cells revealed 1498 gene regulations (Dataset S1b). As reported (Desaint et al., 2004), ∼30% of them were dependent on p53 expression (n = 453; Fig. 1C, left pie). However, ∼85% of these p53-dependent gene regulations (n = 387) were lost in p66−/− MEFs, indicating that p53 transcriptional response to oxidative stress is suppressed in the absence of p66 (p53/p66-dependent gene regulations, Fig. 1C and Dataset S1c). Surprisingly, p66 expression was indispensable for the majority of the H2O2-induced regulations (∼80%; n = 1213; Fig. 1C, right pie).
It is postulated that ROS, which form endogenously from metabolism, induce intracellular oxidative stress that increases during lifespan and is mechanistically implicated in various aging phenotypes (Giorgio et al., 2007; Muller et al., 2007). Thus, we investigated whether p53 and p66 regulate in vivo the same genes regulated in MEFs by H2O2. Expression profiles were obtained from various tissues (thymus, lung, heart and liver) of 2-month-old WT, p53−/− and p66−/− mice. Numbers of p53/p66-dependent gene regulations were highly variable among the analysed tissues and, as in MEFs, they represented a sizeable fractions of the p53-dependent gene regulations (∼65%, ∼36%, ∼33% and ∼15% in thymus, hearth, liver and lung, respectively; Dataset S2 Fig. 1D). Thymus was the tissue with the highest fraction of the same p53-/p66-dependent regulations found in MEFs after H2O2 (∼30% vs. <∼10% in the others; Fig. S2A). Notably, expression profiles of the same tissues from double p53−/− and p66−/− mice (p53/p66-dko) confirmed all the identified p53-/p66-dependent regulations (Fig. S2B and Dataset S2). Together, these data indicate that p53 transcriptional response to oxidative stress in fibroblasts largely depends on p66 and that a similar set of gene regulations is found in vivo.
Finally, we investigated whether the observed p53/p66 transcriptional response was specific to oxidative stress, as compared to other DNA-damaging agents, such as doxorubicin (Doxo). As after H2O2, ∼30% of Doxo-treated MEFs underwent apoptosis at early time-points (Fig. 1A), while the remaining exited the cell cycle (Figs. 1B, right and S1). Analysis of expression profiles from 2 independent MEFs preparations revealed 5,219 gene regulations induced by Doxo, of which only ∼15% (n = 820) were in common with H2O2 (Fig. S2C; Dataset S3). Notably, among these common regulations, we found only ∼19% of the p53-dependent gene regulations observed in MEFs after H2O2, suggesting that p53 transcriptional responses to Doxo and H2O2 differ significantly. Likewise, of the p53-/p66-dependent gene regulations observed in MEFs after H2O2, only a fraction (∼18%; n = 153) was also found in the Doxo dataset. Strikingly, only < 3% (n = 10) of them were regulated in a p66-dependent manner after Doxo, as revealed by expression profiles of Doxo-treated p66−/− MEFs. Accordingly, only ∼11% (n = 587) of all the Doxo-induced gene regulation was p66-dependent. Thus, the p53 transcriptional response to Doxo in MEFs is only partially overlapping with that to H2O2 and does not involve p66. Consistently, while p53−/− MEFs were resistant to Doxo treatment, p66−/− cells entered apoptosis and cell-cycle arrest at the same rates as WT cells (Figs.1A,B and S1).
Gene-ontology analysis of p53-/p66-regulated genes revealed enrichment of cell-cycle genes in MEFs and, alone among the analysed tissues, in the thymus (81 and 390, respectively, 37 in common; Table S1 and Dataset S4a). Most of these genes are involved in G2 or mitosis regulation (G2-M genes; ∼61%, in MEFs and ∼52% in thymus) and were down-regulated by p53 and p66 (∼75% in MEFs and ∼93% in thymus; Fig. 1E).
Gene-chip data were validated by quantitative-PCR (Q-PCR); 19/19 G2-M genes were down-regulated in H2O2-treated MEFs (P < 0.05), but not in p53−/− or p66−/− MEFs (Fig. 2A; Table S2). Experiments were performed in cells from sv/129 or c57bl backgrounds, to exclude effects due to genetic backgrounds. Reconstitution of p53−/− or p66−/− MEFs with WT p53 or p66, respectively, restored oxidative-stress-induced down-regulation. Restoration was not achieved with the redox-defective mQQ-mutant of p66 (Giorgio et al., 2005). Likewise, 6/6 genes were up-regulated in H2O2-treated p53/p66-dko MEFs (Fig. S2D) and in the thymus from 2-month-old p66−/− and p53−/− mice (Fig. 2B). Q-PCR analysis confirmed down-regulation of 18/18 G2-M genes in Doxo-treated WT MEFs; this was lost in the p53−/−, but not in the p66−/− MEFs (Fig. 2C; Table S3). Finally, to investigate if the effect of p66 on the p53 transcriptional response is restricted to H2O2, we tested others oxidative-stress inducers and found down-regulation of 4/4 G2-M genes in WT MEFs treated with canavanine, UV-irradiation or tunicamycin, but not in p53−/− or p66−/− MEFs under the same experimental conditions (Fig. S3A).
We then reviewed available literature to predict the biological consequences of the observed G2-M gene regulations (228 in total; 114 with available genetic and/or biochemical data; Table 1 and Dataset S4b for the complete list of genes and references). ∼90% were down-regulations that included genes required for: (i) mitosis entry or progression (e.g. CDK1, cyclinA and B1, CDC25A/B, Plk1, AuroraA/B, Nek2, Plk1/4); (ii) execution of the various mitotic processes (e.g. Eg5, stathmin and MCAK, CENPC/H and CENPE and Kif22, Ran and BAF complex-components (Baf53a), Smc2/4, the ESPL1, Raf1, Citron and Anillin); (iii) execution of the mitotic spindle checkpoint (Bub1/3, Mad1/2, BubR1 and Mps1). This checkpoint is activated by mis-attachment of microtubules and sister-chromatids to kinetochores and delays mitosis until all kinetochores are properly attached. Reduced levels of several components of the spindle checkpoint, including Bub3 and BubR1, induce cellular senescence and accelerated aging, in the absence of increased cancer formation, suggesting that one function of the spindle checkpoint is the suppression of cellular senescence and aging-associated phenotypes (Baker et al., 2004, 2006).
Thus, down-regulation of the observed G2-M genes by p53 and p66 leads to inhibition of cell proliferation through a block of the G2-M transition or the mitotic process itself, or by acceleration of senescence. Notably, among the few up-regulations, we found genes that induce cell-cycle arrest (e.g. GADD45a, Cyclin G1, BTG2, PPM1A, RPRM).
To investigate whether activation of the p53/p66 transcriptional response to oxidative stress is involved in attenuation of cell proliferation in vivo, as predicted, we analysed expression of the G2-M genes during hepatic regeneration after partial hepatectomy (PH) and physiological involution of the thymus.
In vivo BrdU-labelling showed hepatocytes progressively entering the cell cycle, from ∼0% in the intact liver to ∼15% at 72 h after PH (Figs. 3A and S4A). Q-PCR analysis confirmed that none of the 18 G2-M genes was expressed in the intact liver, but, after PH, showed increasing expression for all of them (Fig. 3B; Table S4). In p53−/− and p66−/− livers, their expression was markedly higher than in controls (Fig. 3B; TableS4). Notably, the p53−/− and p66−/− mice showed increased percentages of cycling cells during regeneration (Figs.3A and S4A).
Analyses of thymuses from 2- to 12-month-old mice showed morphological signs of an involution process (Fig. 3C) associated with decreased organ-weight (Fig. S4B), decreased proliferation and increased senescence (measured as percentages of Ki67- and β-Gal-positivity, respectively; Fig. 3C,D), and marked down-regulation of 23/33 G2-M genes (Fig. 3E and Table S5). Strikingly, thymuses from age-matched p66−/− mice showed a marked delay in the weight-loss and involution process, little variation in the frequency of proliferating and senescent cells and marginal modifications in the expression of G2-M genes. Same analyses in the p53−/− mice were not possible, due to their short lifespan.
Together, these data confirm that one physiological function of the p53/p66 transcriptional programme is to restrict cell proliferation and favour entry into senescence.
Senescent cells accumulate in various tissues and organs with aging and have been causally implicated in generating age-related phenotypes (Baker et al., 2011). We thus investigated expression regulation of G2-M genes during physiological aging, by Q-PCR analysis of various tissues from 3-, 6-, 12- to 24-month-old WT and p66−/− mice (lung, kidney, liver and testis). Results showed, in all tissues, age-dependent reduction in the expression of 31/31 genes. Numbers of down-regulated genes and extent of down-regulation varied in the different tissues, yet they increased over time in all tissues (for example in the lung, the number of down-regulated genes went from ∼54% at 6 months, to ∼63 and 66% at 12–24 months, respectively; (Fig. 4A,B and Table S6).
To investigate mechanisms underlying the effects of p66 on p53, we measured levels of p53 activation and recruitment to target promoters after H2O2. In both WT and p66−/− MEFs, levels of total p53 and p53 acetylation and phosphorylation were barely detectable under basal conditions, while progressively increased after treatment, with a peak at ∼2–3 h (Fig. S4C, left). In p66−/− MEFs, p53 activation was slightly reduced at 3 h after treatment. Notably, this reduction was not detected after Doxo treatment (Fig. S4C, right).
The mechanisms of p53 recruitment to promoters of repressed target genes are not definitively ascertained. It has been reported that, upon genotoxic stress, binding of p53 to the promoter of the CyclinB2 gene (one of our G2-M genes) does not involve canonical p53-binding sites but is mediated by the transcription factor NF-Y (Imbriano et al., 2005). Thus, we measured binding of p53 to the NF-Y sites of the CyclinB2 promoter by chromatin immunoprecipitation (ChIP). As expected, in WT cells, both H2O2 and Doxo treatments induced recruitment of p53 onto the NF-Y binding-sites (Fig. S5). In p66−/− cells instead, we observed impairment of p53 recruitment onto the CyclinB2 promoter, selectively after oxidative stress.
Recent findings suggest that binding of p53 to target promoters is regulated by specific p53 isoforms in the context of specific activating signals (Olivares-Illana & Fahraeus, 2010). p44/p53 is an N-terminally truncated p53 isoform, which forms homo- and hetero-oligomers with p53 and induces G2/M cell-cycle arrest in response to serum deprivation or endoplasmic reticulum (ER) stress (Candeias et al., 2006; Bourougaa et al., 2010). Thus, we investigated whether p44/p53 is involved in the oxidative-stress response of MEFs and whether p66 contributes to its regulation.
p44/p53 was detected in WT MEFs with antibodies against the p53 C-terminal portion (Figs 5A and S6). Levels of p53/p44 increased after treatment with the ER-stress inducer canavanine, as expected, and, to a comparable extent, after H2O2 (Figs 5A and S6). Notably, levels of p44/p53 after H2O2 (or canavanine) were significantly reduced in p66−/− MEFs.
p44/p53 forms from an internal translation-initiation site in the p53 mRNA (Maier et al., 2004; Candeias et al., 2006; Bourougaa et al., 2010) and its translation is regulated by the translation factor eIF2alpha (eIF2α) (Bourougaa et al., 2010). Canavanine, in fact, induces PERK-dependent phosphorylation of eIF2α, which inhibits cap-independent translation of the p53 RNA, thus increasing levels of p44/p53. Phosphorylation of eIF2α was poorly detectable in WT MEFs (Figs 5A and S6). Treatment with canavanine induced eIF2α phosphorylation and increased levels of p66 expression (Figs 5A, left and S6) and phosphorylation (not shown) to an extent comparable with that seen with H2O2 (Figs 5A, right and S6). Notably, phosphorylation of eIF2α after H2O2 (or canavanine) was significantly reduced in p66−/− MEFs. These results suggest that H2O2 treatment, like canavanine, activates p66 and p44/p53 in MEFs, and that p66 expression is critical for p44 activation. Notably, similar regulations of p66, p44/p53 and eIF2α phosphorylation were also observed in MEFs after treatment with canavanine, UV-irradiation or tunicamycin (Fig. S3B).
We then investigated the role of p44/p53 and p66 in cell-cycle regulation after oxidative stress. To this end, we used MEFs from transgenic mice overexpressing p44/p53 (p44Tg mice, Maier et al., 2004) and their intercrosses with p66−/− mice (p44Tg-p66−/−; c57bl/ICR mixed background, see Supporting Experimental Procedures). MEFs were treated with H2O2 and analysed for EdU (5-ethynyl-2′-deoxyuridine)-incorporation, β-Gal-positivity and G2-M gene expression. The frequency of EdU-incorporating cells was ∼70% in the untreated samples (WT, p44Tg and p44Tg-p66−/−). Six days after H2O2 treatment, it decreased to < 20% and < 5%, respectively, in WT and p44Tg MEFs, while it did not change in p44TG-p66−/− MEFs (Fig. S7A). The frequency of β-Gal-positive cells was < 5% in all untreated samples (Figs. S7B,C). After H2O2 treatment, it increased significantly in p44Tg MEFs (∼70 vs. ∼40% in WT), but not in p44Tg-p66−/− MEFs (∼25%;). Doxo-induced senescence, instead, was comparable between p44Tg and p44Tg-p66−/− cells. H2O2-induced down-regulation of 31 G2-M genes was significantly more pronounced in p44Tg MEFs than WT MEFs, and absent in p44Tg-p66−/− MEFs (Fig. 5B, Table S7a). Levels of p53 activation were unchanged in p44Tg MEFs (as compared to WT cells) and slightly reduced in p44Tg-p66−/− MEFs, after either H2O2- or canavanine-treatment (Figs 5C and S8). In conclusion, p44/p53 down-regulates G2-M genes and induces cell-cycle exit selectively after oxidative stress, and this effect depends on p66.
Overexpression of p44Tg leads to increased cellular senescence in various tissues, accelerated aging and shorter lifespan, suggesting that p44/p53 is involved in physiological aging (Maier et al., 2004). Consistently, we found increasing levels of p44/p53 and phosphorylated eIF2α in the liver during chronological aging (Fig. 5D). p53/44 expression in other tissues was too low or nondetectable due to the presence of nonspecific immune-reactive polypeptides comigrating with p44/p53. Notably, expression of p44/p53 and phosphorylated eIF2α were significantly lower in age-matched p66−/− livers, suggesting that p66 regulates activation of p44/p53 in vivo (Fig. 5D).
We then investigated the effects of p44/p53 and p66 on thymus involution. Q-PCR analysis of G2-M gene expression showed significant down-regulation of 33/33 genes in thymuses of 4-month-old p44Tg mice, an effect that was absent in age-matched organs of p44Tg-p66−/− mice (Fig. 5E; Table S7b). At 9 months, expression of the same genes decreased in WT thymuses and was significantly lower in p44Tg organs. Again, this effect of p44/p53 was abrogated in the absence of p66. Thymuses from 4- to 9-month-old mice showed, in p44Tg animals, marked acceleration of organ involution (see haematoxylin and eosin – H&E – staining of the entire organ), progressive loss of proliferating (Ki67-positive) cells, accumulation of senescent (β-Gal-positive) cells and decrease in organ weight (Figs S9 and S10A,B). Strikingly, these features were absent in p44Tg-p66−/− mice. Thus, p44/p53 overexpression increases down-regulation of G2-M genes, exit from the cell-cycle and cellular senescence during thymus involution, and it does it in a p66-dependent manner.
Finally, we analysed the effects of p66 on the aging-phenotypes of p44Tg mice. Postnatal growth-rates in p44Tg mice showed reduced body mass at all time-points (4, 8 and 12 weeks), a phenomenon not observed in p44Tg-p66−/− mice (Fig. 6A). p44Tg mice became infertile as early as ∼5.6 months of age, as reported (Maier et al., 2004), while p44Tg-p66−/− mice continued to reproduce up to ∼8.5 months, like the WT animals (Fig. 6B). Loss of fertility in p44Tg mice was accompanied by loss of sperm-producing cells in the testis, which showed marked reduction in size and weight (Figs 6C and S10C), premature degeneration of the seminiferous epithelium and accumulation of β-Gal-positive cells, all features not observed in p44Tg-p66−/− mice (Fig. S10D). p44Tg mice also showed signs of bone aging at young age (4–7 months), with ∼60% of mice already exhibiting lordokyphosis at 7 months, a phenotype that was observed in only ∼10% of age-matched p44Tg/-p66−/− mice (Figs 6D and S11A). Histomorphometric analysis of H and E-stained sections from the femur (Fig. S11B), and tibia and lumbar spine (data not shown) of p44Tg mice revealed significantly greater reduction in trabecular bone volume (TBV) and osteoblast number at the femur, as compared to WT and p44Tg/p66−/− mice (Fig. 6E). Furthermore, shedding of hair in dorsal and occipital areas (regional alopecia) was more frequent in p44Tg mice (∼30%) than in WT or p44Tg-p66−/− mice (∼9 and 10%, respectively; Figs 6F and S11C). With respect to lifespan, p44Tg mice died considerably earlier than WT (median lifespan: ∼293 days), as reported (Maier et al., 2004). Strikingly, lifespan was considerably longer in p44Tg-p66−/− mice than in p44Tg mice (∼595 days; Fig. 6G; Table S8). Together, these data demonstrate that p66 is critical for p44/p53 acceleration of aging and lifespan shortening in mice.
The role of p53 in ensuring longevity through prevention of cancer is well established. P53 activates a cellular response to DNA damage that leads to a halt in proliferation, via apoptosis or senescence, and is considered a powerful barrier to tumour development (Soussi & Beroud, 2001). Recent evidence, however, suggests that p53 also contributes to aging, though its specific role remains controversial (Feng et al., 2011). Genetically modified mice expressing N-terminally truncated p53 proteins (the artificial ‘m’ p53 mutant or the p44-/p53-natural isoform) exhibit increased p53 activities, resistance to cancer, accelerated aging and reduced lifespan. Cells from these mice are more susceptible to both p53-mediated apoptosis (Tyner et al., 2002) and p53-mediated senescence (Maier et al., 2004), suggesting that enhanced cancer protection comes at the cost of accelerated aging. Consistently, other mutant mice with permanent activation of p53, either by loss of Mdm2 regulation (mice with a hypomorphic mutation in Mdm2) or constitutive DNA instability (mice deficient for telomerase, Ku80 or Brca1), also showed increased apoptosis, senescence or accelerated aging (Vogel et al., 1999; Lim et al., 2000). Thus, the p53-dependent apoptosis/senescence-response to DNA damage may be antagonistically pleiotropic, suppressing tumour formation and promoting early life survival on one hand and causing accumulation of senescent cells and limiting longevity on the other (Feng et al., 2011). Our studies provide evidence for an alternative hypothesis: the tumour suppressor and pro-aging functions of p53 reflect the presence of two distinct p53-signalling pathways.
The DNA-damaging agent Doxo or oxidative stress activate p53 and induce senescence of cultured fibroblasts. We show that p53 transcriptional responses to Doxo or oxidative stress only partially overlap and that the latter is specifically dependent on p66 expression. Consistently, both p53−/− and p66−/− cells are resistant to oxidative stress, while only p53−/− cells are resistant to Doxo.
The p53/p66 transcriptional response to oxidative stress involves down-regulation of a set of ∼200 genes critical for G1/S transition, DNA replication, G2/M transition, mitosis or activation of the spindle checkpoint. Strikingly, most of them are genetic determinants of cell-cycle progression or suppression of senescence, suggesting that their coordinated repression mediates cellular responses to oxidative stress.
Transcription from these genes is usually repressed in G1 and activated in S-phase, to continue in G2 and M. Several of them are characterized by the presence in their promoters of tandem repressor-elements (CDE/CHR), responsible for G1-specific silencing, and upstream CCAAT boxes, through which NF-Y activates transcription in G2-M (Muller & Engeland, 2010) (Dataset S4b). The mechanism underlying repression by p53 is unclear. Available information suggests that it does not require canonical p53-binding sites and depends on intact CCAAT/CDE/CHR/elements (Muller & Engeland, 2010). Notably, our G2-M promoters showed over-representation of the CCAAT/CDE/CHR module and under-representation of p53-binding sites (unpublished), suggesting that they represent a coordinated gene network repressed by p53 through the CCAAT/CDE/CHR/elements.
p53 represses this gene network specifically after oxidative stress (as compared to doxorubicin) and specificity is conferred by p66. p66 is activated by oxidative stress to produce mitochondrial ROS (Giorgio et al., 2005) and is a genetic determinant of transcriptional and cellular responses to oxidative stress (albeit not to doxorubicin), suggesting that it functions as a redox-specific signalling protein to modulate p53 responses. Mechanistically, p66 might exert this effect by activating p44/p53 signalling after oxidative stress. p66, in fact, is activated by oxidative stress and, in this context, is critical for the phosphorylation of eIF2alfa, expression of p44/p53, recruitment of p53 (and possibly p53-p43/p53 heterodimers) to the NFY-binding sites of the CyclinB2 CCAT/CDE/CHR promoter, and the transcriptional effect of p44/p53 on G2-M genes. As down-regulation of G2-M gene transcription requires intact p66 redox activity, p66 might activate p44/p53 signalling by oxidation of relevant substrates. Notably, the redox environment is an important regulator of both eIF2alpha and NF-Y (Jagus & Safer,1981; Bourougaa et al., 2010).
Oxidative stress interferes with disulphide bonding in the lumen of the ER, leading to protein unfolding/misfolding and activation of multiple signal-transduction events (the unfolded protein response). Activation of p66 in proliferating cells, following oxidative stress and protein damage, might favour activation of selected p53-downstream pathways, through p44/p53, leading to transient cell-cycle arrest and repair of damaged proteins, or, if protein damage is severe or protracted, cellular senescence or apoptosis (Kim et al., 2008; Bourougaa et al., 2010). Notably, p66 is critical for the expression of p53/p44 after treatment with the ER-stress inducer canavanine.
Activation of the p53/p44-p66 pathway might also occur in vivo and be implicated in the attenuation of cell proliferation and entry into senescence. We show, in fact, that p53/p66 transcriptional response to oxidative stress is activated in vivo when cells are induced to hyper-proliferate (as in the regenerating hepatocytes) or enter senescence (as during physiological involution of the thymus). Notably, the regenerating liver of p53−/− and p66−/− mice showed increased percentages of cycling cells, while p44/p53 overexpression accelerated accumulation of senescent cells (thymus involution), an effect that was prevented by p66 deletion in both p44/p53 transgenic and WT animals. Thus, one physiological function of the p53/p44-p66 pathway is to restrict cell proliferation and favour entry into senescence.
Strikingly, p66 deletion also abrogated the effects of p44/p53 overexpression on aging and lifespan. Thus, the progressive activation of the p66-p44/p53 pathway in proliferating cells of various tissues, due to the accumulation of oxidative stress, might contribute to physiological aging and limit lifespan. Abrogation of this pathway, however, is not expected to increase tumour formation. In p66−/− cells, doxorubicin activates p53 and induces senescence and apoptosis, suggesting that different and nonredundant p53 pathways can be activated by protein or DNA damage, which might differently contribute to aging and tumour suppression.
Details of strain are reported in Supporting Information (SI), Experimental Procedure Section. Affymetrix screenings were conducted on tissues and cells obtained from WT, p66−/− or p53−/− mice in the sv/129 background. Q-PCR validations and in vivo analyses were performed in cells and tissues from wt, p66−/− or p53−/− mice in the sv/129 or c57bl backgrounds (to investigate the effects of different genetic backgrounds on our findings). In the p44Tg experiments, we used WT, p44Tg and p44Tg-p66−/− in the mixed c57bl/ICR background (see SI).
Primary murine embryonic fibroblasts (MEFs) were isolated from 13.5-day-old embryos according to standard procedures. Senescence, apoptosis and proliferation assay are described in SI.
We conducted analysis with the gene-expression series dataset deposited in the NCBI's Gene-Expression Omnibus and are accessible through GEO Series accession number GSE28418. All technical information on Affymetrix screening, Quantitative-PCR and Gene-Ontology analysis are reported in SI.
Western blots were generated using standard procedures. Details in SI.
Four micrometer thick sections of the prepared organs were used for all staining described in SI.
Detailed description of the surgical procedure is reported in SI.
The Kaplan–Meier method was used to plot survival curves, and the log-rank test was used to determine the statistical significance of the differences scored between survival curves. Statistical analysis was performed using JMP statistical software. Raw data of survival experiment are reported in SI, Table S8.
Data are presented as the mean ± standard deviation (SD) and analysed by the Student's t-test in n > 3 independent experiments. Differences between means were assessed by two-way analysis of variance. The minimum level of significance was set at P < 0.05.
We thank B. Amati, M. Cesaroni, G. D'Ario, A. Gobbi and N. Offenhauser for critical discussions. P. Dalton and R. Aina for manuscript editing, M. Stendardo, R. D'Antuono and D. Piobbico for technical assistance. This study was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant ID 10690 awarded to E.M, in part by National Institute of Health Grant 1P01AG025532-01A1 awarded to PG and in part by Associazione Umbra Contro il Cancro (AUCC).
VG and EM conceived and designed the experiments. VG, GDM, OV, PM, VDO performed the experiments. GDM, MADF, DB, GS performed PH experiments. LB, SPM, LL conducted all bioinformatics analyses. MA, HS, MG contributed to reagents and gave conceptual advice. EM and PGP analysed data, supervised the project and wrote the manuscript.
|Alderman JM,Flurkey K,Brooks NL,Naik SB,Gutierrez JM,Srinivas U,Ziara KB,Jing L,Boysen G,Bronson R,Klebanov S,Chen X,Swenberg JA,Stridsberg M,Parker CE,Harrison DE,Combs TP. Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf miceExp. GerontolYear: 200944263318582556|
|Baker DJ,Jeganathan KB,Cameron JD,Thompson M,Juneja S,Kopecka A,Kumar R,Jenkins RB,de Groen PC,Roche P,van Deursen JM. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in miceNat. GenetYear: 20043674474915208629|
|Baker DJ,Jeganathan KB,Malureanu L,Perez-Terzic C,Terzic A,van Deursen JM. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient miceJ. Cell BiolYear: 200617252954016476774|
|Baker DJ,Wijshake T,Tchkonia T,LeBrasseur NK,Childs BG,van de Sluis B,Kirkland JL,van Deursen JM. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disordersNatureYear: 201147923223622048312|
|Bluher M,Kahn BB,Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissueScienceYear: 200329957257412543978|
|Bluher M,Patti ME,Gesta S,Kahn BB,Kahn CR. Intrinsic heterogeneity in adipose tissue of fat-specific insulin receptor knock-out mice is associated with differences in patterns of gene expressionJ. Biol. ChemYear: 2004279318913190115131119|
|Bokov A,Chaudhuri A,Richardson A. The role of oxidative damage and stress in agingMech. Ageing DevYear: 200412581182615541775|
|Bourougaa K,Naski N,Boularan C,Mlynarczyk C,Candeias MM,Marullo S,Fahraeus R. Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47Mol. CellYear: 201038788820385091|
|Brown-Borg HM. Longevity in mice: is stress resistance a common factor?Age (Dordr)Year: 20062814516219943136|
|Candeias MM,Powell DJ,Roubalova E,Apcher S,Bourougaa K,Vojtesek B,Bruzzoni-Giovanelli H,Fahraeus R. Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiationOncogeneYear: 2006256936694716983332|
|Desaint S,Luriau S,Aude JC,Rousselet G,Toledano MB. Mammalian antioxidant defences are not inducible by H2O2J. Biol. ChemYear: 2004279311573116315155764|
|Feng Z,Lin M,Wu R. The regulation of aging and longevity: a new and complex role of p53Genes CancerYear: 2011244345221779512|
|Giorgio M,Migliaccio E,Orsini F,Paolucci D,Moroni M,Contursi C,Pelliccia G,Luzi L,Minucci S,Marcaccio M,Pinton P,Rizzuto R,Bernardi P,Paolucci F,Pelicci PG. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosisCellYear: 200512222123316051147|
|Giorgio M,Trinei M,Migliaccio E,Pelicci PG. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?Nat. Rev. Mol. Cell BiolYear: 2007872272817700625|
|Gutierrez-Uzquiza A,Arechederra M,Molina I,Banos R,Maia V,Benito M,Guerrero C,Porras A. C3G down-regulates p38 MAPK activity in response to stress by Rap-1 independent mechanisms: involvement in cell deathCell. SignalYear: 20102253354219925863|
|Hauck SJ,Aaron JM,Wright C,Kopchick JJ,Bartke A. Antioxidant enzymes, free-radical damage, and response to paraquat in liver and kidney of long-living growth hormone receptor/binding protein gene-disrupted miceHorm. Metab. ResYear: 20023448148612384824|
|Huang TT,Carlson EJ,Gillespie AM,Shi Y,Epstein CJ. Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in miceJ. Gerontol. A Biol. Sci. Med. SciYear: 200055B5B910719757|
|Hursting SD,Perkins SN,Phang JM. Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic miceProc. Natl Acad. Sci. U.S.AYear: 199491703670408041741|
|Ikeno Y,Bronson RT,Hubbard GB,Lee S,Bartke A. Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevityJ. Gerontol. A Biol. Sci. Med. SciYear: 20035829129612663691|
|Ikeno Y,Hubbard GB,Lee S,Cortez LA,Lew CM,Webb CR,Berryman DE,List EO,Kopchick JJ,Bartke A. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout miceJ. Gerontol. A Biol. Sci. Med. SciYear: 20096452252919228785|
|Imbriano C,Gurtner A,Cocchiarella F,Di Agostino S,Basile V,Gostissa M,Dobbelstein M,Del Sal G,Piaggio G,Mantovani R. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promotersMol. Cell. BiolYear: 2005253737375115831478|
|Jagus R,Safer B. Activity of eukaryotic initiation factor 2 is modified by processes distinct from phosphorylation. II. Activity of eukaryotic initiation factor 2 in lysate is modified by oxidation-reduction state of its sulfhydryl groupsJ. Biol. ChemYear: 1981256132413297451508|
|Jang YC,Perez VI,Song W,Lustgarten MS,Salmon AB,Mele J,Qi W,Liu Y,Liang H,Chaudhuri A,Ikeno Y,Epstein CJ,Van Remmen H,Richardson A. Overexpression of Mn superoxide dismutase does not increase life span in miceJ. Gerontol. A Biol. Sci. Med. SciYear: 2009641114112519633237|
|Johnson TM,Yu ZX,Ferrans VJ,Lowenstein RA,Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosisProc. Natl Acad. Sci. U.S.AYear: 19969311848118528876226|
|Kim I,Xu W,Reed JC. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunitiesNat. Rev. Drug DiscovYear: 200871013103019043451|
|Lim DS,Vogel H,Willerford DM,Sands AT,Platt KA,Hasty P. Analysis of ku80-mutant mice and cells with deficient levels of p53Mol. Cell. BiolYear: 2000203772378010805721|
|Lim Y,Lee E,Lee J,Oh S,Kim S. Down-regulation of asymmetric arginine methylation during replicative and H2O2-induced premature senescence in WI-38 human diploid fibroblastsJ. BiochemYear: 200814452352918676353|
|Maier B,Gluba W,Bernier B,Turner T,Mohammad K,Guise T,Sutherland A,Thorner M,Scrable H. Modulation of mammalian life span by the short isoform of p53Genes DevYear: 20041830631914871929|
|Migliaccio E,Giorgio M,Mele S,Pelicci G,Reboldi P,Pandolfi PP,Lanfrancone L,Pelicci PG. The p66shc adaptor protein controls oxidative stress response and life span in mammalsNatureYear: 199940230931310580504|
|Migliaccio E,Giorgio M,Pelicci PG. Apoptosis and aging: role of p66Shc redox proteinAntioxid. Redox SignalYear: 2006860060816677103|
|Muller GA,Engeland K. The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcriptionFEBS JYear: 201027787789320015071|
|Muller FL,Lustgarten MS,Jang Y,Richardson A,Van Remmen H. Trends in oxidative aging theoriesFree Radic. Biol. MedYear: 20074347750317640558|
|Olivares-Illana V,Fahraeus R. p53 isoforms gain functionsOncogeneYear: 2010295113511920622898|
|Perez VI,Van Remmen H,Bokov A,Epstein CJ,Vijg J,Richardson A. The overexpression of major antioxidant enzymes does not extend the lifespan of miceAging CellYear: 20098737519077044|
|Perez VI,Cortez LA,Lew CM,Rodriguez M,Webb CR,Van RemmenH,Chaudhuri A,Qi W,Lee S,Bokov A,Fok W,Jones D,Richardson A,Yodoi J,Zhang Y,Tominaga K,Hubbard GB,Ikeno Y. Thioredoxin 1 overexpression extends mainly the earlier part of life span in miceJ. Gerontol. A Biol. Sci. Med. SciYear: 2011661286129921873593|
|Ristow M,Schmeisser S. Extending life span by increasing oxidative stressFree Radic. Biol. MedYear: 20115132733621619928|
|Salmon AB,Murakami S,Bartke A,Kopchick J,Yasumura K,Miller RA. Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stressAm. J. Physiol. Endocrinol. MetabYear: 2005289E23E2915701676|
|Salmon AB,Richardson A,Perez VI. Update on the oxidative stress theory of aging: does oxidative stress play a role in aging or healthy aging?Free Radic. Biol. MedYear: 20104864265520036736|
|Schriner SE,Linford NJ,Martin GM,Treuting P,Ogburn CE,Emond M,Coskun PE,Ladiges W,Wolf N,Van Remmen H,Wallace DC,Rabinovitch PS. Extension of murine life span by overexpression of catalase targeted to mitochondriaScienceYear: 20053081909191115879174|
|Soussi T,Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcomeNat. Rev. CancerYear: 2001123324011902578|
|Trinei M,Giorgio M,Cicalese A,Barozzi S,Ventura A,Migliaccio E,Milia E,Padura IM,Raker VA,Maccarana M,Petronilli V,Minucci S,Bernardi P,Lanfrancone L,Pelicci PG. A p53–p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosisOncogeneYear: 2002213872387812032825|
|Tyner SD,Venkatachalam S,Choi J,Jones S,Ghebranious N,Igelmann H,Lu X,Soron G,Cooper B,Brayton C,Park SH,Thompson T,Karsenty G,Bradley A,Donehower LA. p53 mutant mice that display early ageing-associated phenotypesNatureYear: 2002415455311780111|
|Vogel H,Lim DS,Karsenty G,Finegold M,Hasty P. Deletion of Ku86 causes early onset of senescence in miceProc. Natl Acad. Sci. U.S.AYear: 199996107701077510485901|
|Zhang Y,Ikeno Y,Qi W,Chaudhuri A,Li Y,Bokov A,Thorpe SR,Baynes JW,Epstein C,Richardson A,Van Remmen H. Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevityJ. Gerontol. A Biol. Sci. Med. SciYear: 2009641212122019776219|
Additional Supporting Information may be found in the online version of this article at the publisher's web-site.
Fig. S1 p66 is required for oxidative stress-induced senescence and apoptosis.
Fig. S2 p53 transcriptional-response to oxidative stress in MEFs and thymus depends on p66 expression and involves genes that suppress the G2/M transition or mitosis.
Fig. S3 p53-p66 dependent transcriptional response at several sources of free radicals.
Fig. S4 p53/p66 transcriptional-response in regenerating hepatocytes and during involution of the thymus.
Fig S5 Binding of p53 to the NF-Y sites of the CyclinB2 promoter by chromatin immunoprecipitation (ChIP) in WT and p66−/− MEFs.
Fig. S6 Densitometry analysis.
Fig. S7 p66 deletion rescues senescence of p44Tg MEFs.
Fig. S8 Densitometry analysis.
Fig. S9 Representative images of thymus from 4 and 9 month-old WT, p44Tg and p44Tg-p66−/− animals.
Fig. S10 Effects of p66 on the aging-phenotypes of p44Tg mice.
Fig. S11 More effects of p66 on the aging phenotypes of p44Tg mice.
Dataset S1 Gene expression changes in response to H2O2 in WT, p53−/− and p66Shc−/− MEFs MEFs.
Dataset S2 Gene expression changes in tissues from 2-month oldWT, p66−/− p53−/− and p53/p66dko mice.
Dataset S3 Gene expression changes in response to Doxorubicin in WT and p66−/−MEFs.
Dataset S4 p53/p66-dependent gene regulations involved in cell-cycle control.
Table S1 Functional enrichment of p53/p66-regulated genes.
Table S2 Raw data for expression analysis on main Figure 2A is presented.
Table S3. Raw data for expression analysis on main Figure 2C is presented.
Table S4. Raw data for expression analysis on main Figure 3B is presented.
Table S5 Raw data for expression analysis on main Figure 3E is presented.
Table S6 (a) Raw data for expression analysis on main Figure 4 is presented.
Table S8 Delayed aging in p44Tg and p44Tg-p66−/− mice.Click here for additional data file (acel0012-0435-SD1.jpg)
Click here for additional data file (acel0012-0435-SD2.jpg)
Click here for additional data file (acel0012-0435-SD3.jpg)
Click here for additional data file (acel0012-0435-SD4.jpg)
Click here for additional data file (acel0012-0435-SD5.jpg)
Click here for additional data file (acel0012-0435-SD6.jpg)
Click here for additional data file (acel0012-0435-SD7.jpg)
Click here for additional data file (acel0012-0435-SD8.jpg)
Click here for additional data file (acel0012-0435-SD9.jpg)
Click here for additional data file (acel0012-0435-SD10.jpg)
Click here for additional data file (acel0012-0435-SD11.jpg)
Click here for additional data file (acel0012-0435-SD12.xls)
Click here for additional data file (acel0012-0435-SD13.xls)
Click here for additional data file (acel0012-0435-SD14.xlsx)
Click here for additional data file (acel0012-0435-SD15.xlsx)
Click here for additional data file (acel0012-0435-SD16.doc)
[Figure ID: fig01]
p66 is required for oxidative stress-induced senescence and apoptosis. (A) Apoptosis analysis by FACS (left) and Western blot (right) of cleaved caspase-3 expression in WT, p66−/− and p53−/− MEFs after H2O2 or Doxorubicin (Doxo) treatment; (n = 3 Error bars represent standard deviation (SD). (B) EdU (5-ethynyl-2′-deoxyuridine) incorporation (left) and β-Gal quantification (right) of WT, p66−/− and p53-/- MEFs after H2O2 or Doxo treatment; average of 3 independent experiments. Error bars represent SD. (C) The two pies show the number of statistically significant H2O2-induced gene-regulations in WT MEFs (n = 1498), and their dependence on p53 (n = 453; left pie) or p66 (n = 1213; right pie) expression, as derived from the comparison of the WT vs. p53−/− or p66−/− datasets, respectively. The bar of pie (left pie) shows the number of p53-dependent regulations that were also dependent on p66 expression (n = 387) or not (n = 66). (D) The graph shows the number of genes regulated by p66, p53 or both in the indicated tissues in physiological conditions. (E) Distribution (percentage) of the genes regulated by p53 and p66 in both H2O2-treated MEFs and thymus (up- or down-regulations), according to their indicated functions in the cell-cycle.
[Figure ID: fig02]
Q-PCR validation of p53-p66 dependent regulations of G2-M genes in MEFs and thymus. (A) Left: Box plot representation of Q-PCR fold-changes (FC) for 19 G2-M genes in H2O2-treated MEFs (compared with untreated controls): WT, p53−/−, p53−/− + p53 (p53−/− MEFs reconstituted with WT p53), p66−/−, p66−/− + p66 (p66−/− MEFs reconstituted with WT p66), and p66−/− + QQ (p66−/− MEFs reconstituted with the p66 redox-mutant QQ). Right, representative example: mRNA-expression levels of the bub1b gene in control and H2O2 treated MEFs with the indicated genotypes by Q-PCR analysis. (B) Significant up-regulation of the mRNA levels of several G2/M genes in 2-month-old p66−/− and p53−/− thymuses compared to WT organs (QPCR, 8 animals per genotype). (C) Left: Box plot representation of Q-PCR FC for 18 G2-M genes in Doxo-treated MEFs (compared with untreated controls): WT, p66−/−, p53−/−, p53−/− + p53 (p53−/− MEFs reconstituted with WT p53), p66−/− + p66 (p66−/− MEFs reconstituted with WT p66). Right, representative example: mRNA-expression levels of the bub1b gene in control and Doxo-treated MEFs with the indicated genotypes by Q-PCR analysis. FC are compared with untreated controls; error bars represent SD; (H2O2- independent experiments: n = 4; Doxo- independent experiments: n = 2). Significant P-values are indicated(two-tailed t-test). The lower and the upper edges of each box plot are the 1st and 3rd quartile, respectively (inter quartile range, IQR). The line in the middle of the box represents the median. The observations beyond the fences are denoted as circles and are considered outliers.
[Figure ID: fig03]
p53 and p66 down-regulate G2-M genes in the thymus during physiological aging and in proliferating liver cells. (A) Higher percentage of proliferating cells in p66−/− regenerating liver. Quantitative analysis of BrdU staining during liver regeneration of 2-month-old WT, p66−/− and p53−/− mice: liver samples were collected before resection (time zero, T0; preoperative livers) and 24, 36, 48 and 72 h after partial hepatectomy. Error bars represent SD; average of 2 independent experiments on a total of 6 animals per group. Ratio of BrdU positive to 600 Dapi positive hepatocytes at every time-point are represented; significant P-values are indicated (two-tailed t-test that were done by comparing data set of p66−/− or p53−/−at each time-point with the corresponding data set of WT samples). (B) G2-M genes are regulated during hepatic regeneration. Box plot representation of Q-PCR fold-changes (FC) for 18 of the G2-M genes on RNAs from livers of 2-month-old WT and p66−/− mice during hepatic regeneration. For each sample we pooled RNAs from 3 animals. Average of 2 independent experiments is represented. (C,D) Delayed aging in p66−/− thymus. (C) Representative images from 3 independent experiments showing H&E (top, digital reconstructions), Ki67 (centre) and β-Gal (bottom) staining of thymuses from 2- and 12-month-old WT and p66−/− mice. Scale bar: 200 μm. (D) Quantification of the frequency of Ki-67- (left) and β-Gal- (right) positive cells. P-values with respect to WT are indicated. (E) Box plot representation of the Q-PCR FC for 33 G2-M genes in 2- and 12-month-old p66−/− thymuses compared to 2-month-old WT organs (FC=1); n = 8 animals per genotype.
[Figure ID: fig04]
p53/p66 transcriptional-response to oxidative stress is activated during physiological aging. (A,B) Q-PCR analysis of lung, liver, kidney, and testis from 3, 6, 12 and 24 month-old WT and p66−/− mice. Heatmap (A) and box plot (B) representations of the expression profile of 31 G2-M genes significantly downregulated during physiological aging. For each gene, averaged tissue expression (2 mice per genotype per age group) at the indicated ages is compared with that of the corresponding tissue of 3-month-old mice (FC=1). (A) Darker blue colours indicate greater fold changes. (B) The lower and the upper edges of the box are the 1st and 3rd quartile, respectively (inter quartile range, IQR). The line in the middle of the box represents the median. The observations beyond the fences are denoted as circles and are considered outliers.
[Figure ID: fig05]
p66 loss interferes with p53/p44 activation upon endoplasmic reticulum (ER) stress. (A) Western blot analysis of proteins extracted from control and treated [canavanine (left) or H2O2 (right)] WT, p66−/− and p53−/− MEFs at the indicated time-points. Immunoblotting was performed with antibodies against: P-eIF2α, p66, p53 (AI25-13, anti-full length p53), and vinculin. (B) Effect of p66 deletion on the expression of 31 G2-M genes in p44Tg samples. Box plot representation of Q-PCR fold-changes (FC), with respect to the untreated controls, for the G2-M genes in H2O2-treated WT (WT+H), p44Tg (p44Tg+H) and p44Tg/p66−/− (p44Tg-p66−/−+H) MEFs. Average of 3 independent experiments. (C) Western blot analysis of proteins extracted from control and treated [canavanine (upper) or H2O2 (lower)] WT, p44Tg and p44Tg-p66−/− MEFs at the indicated timepoints. Immunoblotting was performed with antibodies against: p53 (DO-1, anti-N-terminal region), phosphorylated-p53 (P-p53), acetylated-p53 (Ac-p53) and vinculin. (D) Western blot analysis of proteins extracted from liver of 3, 6 and 12 month-old WT and p66−/− mice (m1, m2: 2 mice for each age group). Immunoblotting was performed with anti-p53 (AI25-13, anti full-length p53), anti-P-eIF2α and anti-vinculin antibodies. (E) Box plot representation of Q-PCR FC for the expression of G2-M genes in the thymuses of 4 and 9 month-old WT, p44Tg and p44Tg/p66−/− mice (4 animals per genotype). FC are compared with those of 4-month-old WT mice (FC=1).
[Figure ID: fig06]
Effects of p66 on the aging-phenotypes of p44Tg mice. (A) Body weight of WT, p44Tg and p44Tgp66−/− mice at 4, 8 and 12 weeks of age; average of 10 males per group.(B) Box plot representation of the last fertile age (in months) of p44Tg and p44Tg-p66−/− mice (20 males per group). The lower and the upper edges of the box are the 1st and 3rd quartile, respectively (inter quartile range, IQR). The line in the middle of the box represents the median (5.6 months for p44Tg and 8.5 months for p44Tg-p66−/−). (C) Testis weight of 5-month-old WT, p44Tg and p44Tg-p66−/− mice (average from 10 mice per group) (D) Percentage of lordokyphosis in p44Tg and p44Tg-p66−/−mice (n = 60). (E) Histomorphometric analysis of H&E sections (Fig. S10B) from the femur of different p44Tg and p44Tg-p66−/−mice of the same age (9 months; n = 3). Left: osteoblast number/bone surface ratio (osteoblast/mm BS). Right: trabecular bone volume (TBV). (F) Percentage of alopecia in 7-month-old WT, p44Tg and p44Tg-p66−/− mice for each group (n = 50). (G) Kaplan–Mayer representation of the lifespan of p44Tg (n = 49) and p44Tg-p66−/− (n = 55) mice (Table S8). Error bars represent SD; significant P-values are indicated (two-tailed t-test).
Biological function of G2/M p53p66 dependent genes
|Biological function||No of genes||Examples||Reg||Unigene|
|Execution of mitotic processes||80|
|Kinetocore and spindle formation||CENPC1||D||Mm.4649|
|Nuclear envelope breakdown (NBD)||ACTL6A (Baf53a)||D||Mm.41077|
|Loss of sister-chromatid chohesion||CDC20||D||Mm.396441|
|Other execution of mitotic processes||NUMA1||D||Mm.27259|
|Exection of the mitotic spindle checkpoint||10||BUB1||D||Mm.2185|
This table includes examples of genes grouped into five functional classes (bolded) for which literature data are available to assign a function in the G2/M transition or mitosis.
Keywords: aging genes, oxydative stress, p53, senescence.
Previous Document: Do the digestive tract symptoms in eating disorder patients represent functional gastrointestinal di...
Next Document: Serum selenium is low in newly diagnosed Graves'disease. A population based study.